Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Corvus Pharmaceuticals Inc banner

Corvus Pharmaceuticals Inc
F:C17

Watchlist Manager
Corvus Pharmaceuticals Inc Logo
Corvus Pharmaceuticals Inc
F:C17
Watchlist
Price: 10.005 EUR -0.25% Market Closed
Market Cap: €625.8m
Write Note Create Alert Ask AI

Profitability Summary

Corvus Pharmaceuticals Inc's profitability score is 15/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

15 / 100
Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

15 / 100
Profitability
Score
15 / 100
Profitability
Score

Margins

Earnings Waterfall
Corvus Pharmaceuticals Inc

Margins Comparison
Corvus Pharmaceuticals Inc Competitors

Return on Capital

Return on Capital Comparison
Corvus Pharmaceuticals Inc Competitors

Free Cash Flow

Continue C17 Research

Summary
C17 intrinsic value, competitors valuation, and company profile.
DCF Valuation
C17 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
C17 stock valuation using valuation multiples.
Wall St Estimates
C17 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
C17 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Corvus Pharmaceuticals Inc listings:
NASDAQ • USD
CRVS
 SWB • EUR
C17
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join 359,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.